Conclusion on cost-effectiveness of rotavirus vaccination highly dependent on assumptions.
Goossens
Lucas
L
Standaert
Baudouin
B
Hartwig
Nico
N
Hövels
Anke M
AM
Al
Maiwenn J
MJ
D003362:Cost-Benefit Analysis; D006801:Humans; D009426:Netherlands; D012400:Rotavirus Infections / Q000191:economics* / Q000517:prevention & control*; D022243:Rotavirus Vaccines / Q000191:economics* / Q000276:immunology*; D014611:Vaccination / Q000191:economics* / Q000706:statistics & numerical data*
D022243:Rotavirus Vaccines